<DOC>
	<DOC>NCT01366378</DOC>
	<brief_summary>This open-label study assesses the single-dose pharmacokinetics of intravenously-administered MNTX in healthy adult male and female subjects in the absence of, and in the presence of, orally-administered cimetidine.</brief_summary>
	<brief_title>Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX</brief_title>
	<detailed_description />
	<mesh_term>Cimetidine</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1. Healthy males and females between the ages of 18 and 45 2. Subjects who are nonsmokers 3. Subjects with body weights with range of 154220 lbs. 1. Females who are pregnant or lactating 2. Subjects with a history of any clinically significant disease or condition affecting a major organ system 3. Subjects with ECG abnormalities 4. Subjects who have tested positive for hepatitis B, hepatitis C or HIV 5. Subjects who have had a diagnosis of alcohol or substance dependence with the past 12 months 6. Subjects with positive urine results for drugs of abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>